(TSX:DBM),(TSX:DBM-NT), THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Q1 2025 Financial Highlights(1): Revenues of $793.2 million Gross Margin at 16.7% Adjusted EBITDA(2)(3) amounted to $70.0 million Net Earnings amounted to $23.6 million Quarterly dividend of […]
(NASDAQ:PCRX), — Conference call today at 4:30 p.m. ET — BRISBANE, Calif., May 08, 2025 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today reported financial results for the first quarter of 2025. First Quarter 2025 Financial
(NYSE:BKKT), NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Bakkt Holdings, Inc. (“Bakkt” or “the Company”) (NYSE: BKKT) and certain of its officers. Class Definition This lawsuit seeks to recover damages
(NASDAQ:CYTK), SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced three Late Breaking Science presentations and one ePoster presentation at Heart Failure 2025, an International Congress of the European Society of Cardiology, taking place in Belgrade, Serbia from May 17, 2025 – May 20, 2025. Late Breaking Science
(NasdaqGM:CLFD), Company returns to profitability, generating net income per diluted share of $0.09 Revenue of $47.2 million driven by 47% year-over-year growth in the Clearfield Segment Company focused on executing to opportunity, yet economic uncertainty leads the Company to reiterate fiscal 2025 net sales guidance in the range of $170 million to $185 million MINNEAPOLIS,
(CNSX:JUSH),(CNSX:JUSH.CN),(OTC US:JUSHF),(Other OTC:JUSHF), Retail-First Growth Strategy Continues with 40 Operational Locations Nationwide at Quarter-End and Five Additional Stores Expected to Open by Year-End Strengthened Balance Sheet Through Strategic Transactions to Support Continued Expansion Net Loss of $17.0 million, compared to $12.5 million in the fourth quarter of 2024 Adjusted EBITDA Grew 22.8% Sequentially to $9.8
(NASDAQ:EU), NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) — Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against enCore Energy Corp. (“enCore” or “the Company”) (NASDAQ: EU) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants
(NYSE:TFII), NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) — Attorney Advertising– Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against TFI International Inc. (“TFI” or “the Company”) (NYSE: TFII) and certain of its officers. Class Definition This lawsuit seeks to recover damages against
(NYSE:IBTA), NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Ibotta, Inc. (“Ibotta” or “the Company”) (NYSE: IBTA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against
Pacira BioSciences Reports First Quarter 2025 Financial Results GlobeNewswire May 08, 2025 — Conference call today at 4:30 p.m. ET — BRISBANE, Calif., May 08, 2025 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today reported financial